Maintenance Transcranial Electrical Stimulation for Depression
A Study of Transcranial Electrical Stimulation (TES) as a Maintenance Treatment for Depression
1 other identifier
interventional
25
1 country
1
Brief Summary
Transcranial electrical stimulation (TES) techniques offer a novel treatment approach for depression and have shown promising efficacy. However, there is no published data to date on their effectiveness as a maintenance treatment. This study will investigate ways of using TES as a maintenance treatment to prevent relapse in depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable major-depressive-disorder
Started Jun 2013
Longer than P75 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 26, 2013
CompletedFirst Posted
Study publicly available on registry
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedMarch 27, 2018
March 1, 2018
4.7 years
June 26, 2013
March 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Montgomery Asberg Depression Rating Scale for Depression (MADRS)
9 months
Study Arms (1)
Transcranial electrical stimulation
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- All participants will be ≥ 18 years old.
- Participants must have experienced a significant clinical response, defined as ≥ 50% decrease from baseline scores on the Montgomery Asberg Depression Rating Scale (MADRS).
You may not qualify if:
- Inadequate response to acute trial of TES.
- Suicidality.
- Clinically defined neurological disorder or insult.
- Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
- Pregnancy (women of childbearing age will be asked to undergo a urine pregnancy test prior to starting the study).
- Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.
- Treatment for depression is changed during months 3-9 of the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Black Dog Institute / University of New South Wales
Randwick, Sydney, New South Wales, 2031, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Colleen Loo, MBBS
University of New South Wales
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 26, 2013
First Posted
July 1, 2013
Study Start
June 1, 2013
Primary Completion
February 1, 2018
Study Completion
February 1, 2018
Last Updated
March 27, 2018
Record last verified: 2018-03